111 related articles for article (PubMed ID: 20515277)
1. Clinical validity: defining biomarker performance.
Bossuyt PM
Scand J Clin Lab Invest Suppl; 2010; 242():46-52. PubMed ID: 20515277
[TBL] [Abstract][Full Text] [Related]
2. Interpreting diagnostic test accuracy studies.
Bossuyt PM
Semin Hematol; 2008 Jul; 45(3):189-95. PubMed ID: 18582626
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy measures.
Eusebi P
Cerebrovasc Dis; 2013; 36(4):267-72. PubMed ID: 24135733
[TBL] [Abstract][Full Text] [Related]
4. Lack of generalizability of sensitivity and specificity with treatment effects.
Dodd LE; Korn EL
Stat Med; 2008 May; 27(10):1734-44. PubMed ID: 17940996
[TBL] [Abstract][Full Text] [Related]
5. The relationships among performance measures in the selection of diagnostic tests.
Einstein AJ; Bodian CA; Gil J
Arch Pathol Lab Med; 1997 Feb; 121(2):110-7. PubMed ID: 9126035
[TBL] [Abstract][Full Text] [Related]
6. Use of diagnostic accuracy as a metric for evaluating laboratory proficiency with microarray assays using mixed-tissue RNA reference samples.
Pine PS; Boedigheimer M; Rosenzweig BA; Turpaz Y; He YD; Delenstarr G; Ganter B; Jarnagin K; Jones WD; Reid LH; Thompson KL
Pharmacogenomics; 2008 Nov; 9(11):1753-63. PubMed ID: 19018728
[TBL] [Abstract][Full Text] [Related]
7. Study design for the evaluation of diagnostic tests.
Daya S
Semin Reprod Endocrinol; 1996 May; 14(2):101-9. PubMed ID: 8796932
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the added value of a diagnostic test or marker.
Moons KG; de Groot JA; Linnet K; Reitsma JB; Bossuyt PM
Clin Chem; 2012 Oct; 58(10):1408-17. PubMed ID: 22952348
[TBL] [Abstract][Full Text] [Related]
9. Standardization of protein biomarker measurements: is it feasible?
Schimmel H; Zegers I; Emons H
Scand J Clin Lab Invest Suppl; 2010; 242():27-33. PubMed ID: 20515273
[TBL] [Abstract][Full Text] [Related]
10. Measurement error in biomarkers: sources, assessment, and impact on studies.
White E
IARC Sci Publ; 2011; (163):143-61. PubMed ID: 22997860
[TBL] [Abstract][Full Text] [Related]
11. Measurement performance goals: how they can be estimated and a view to managing them.
Kallner A
Scand J Clin Lab Invest Suppl; 2010; 242():34-9. PubMed ID: 20515274
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of commercialized rapid diagnostic testing for some Hepatitis B biomarkers in an area of intermediate endemicity.
El-Ghitany EM; Farghaly AG
J Virol Methods; 2013 Dec; 194(1-2):190-3. PubMed ID: 24004823
[TBL] [Abstract][Full Text] [Related]
13. Approval of novel biomarkers: FDA's perspective and major requests.
Scherf U; Becker R; Chan M; Hojvat S
Scand J Clin Lab Invest Suppl; 2010; 242():96-102. PubMed ID: 20515286
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in evaluating the prognostic value of a marker.
Dalton JE; Kattan MW
Scand J Clin Lab Invest Suppl; 2010; 242():59-62. PubMed ID: 20515279
[TBL] [Abstract][Full Text] [Related]
15. Validation of hemostasis and coagulation assays: recommendations and guidelines.
Marlar RA; Gausman JN; Engel JW
Semin Thromb Hemost; 2014 Mar; 40(2):186-94. PubMed ID: 24497118
[TBL] [Abstract][Full Text] [Related]
16. Performance of Xpert MTB/RIF on pleural tissue for the diagnosis of pleural tuberculosis.
Christopher DJ; Schumacher SG; Michael JS; Luo R; Balamugesh T; Duraikannan P; Pollock NR; Pai M; Denkinger CM
Eur Respir J; 2013 Nov; 42(5):1427-9. PubMed ID: 23900990
[No Abstract] [Full Text] [Related]
17. Validation of neurokinin a assays in the United States and Europe.
Mamikunian P; Ardill JE; O'Dorisio TM; Krutzik SR; Vinik AI; Go VL; Armstrong L; Mamikunian G; Woltering EA
Pancreas; 2011 Oct; 40(7):1000-5. PubMed ID: 21926539
[TBL] [Abstract][Full Text] [Related]
18. Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases.
Giesing M; Driesel G; Molitor D; Suchy B
BJU Int; 2012 Dec; 110(11 Pt C):E1202-11. PubMed ID: 23046102
[TBL] [Abstract][Full Text] [Related]
19. Statistical evaluation of test accuracy studies for Toxoplasma gondii in food animal intermediate hosts.
Gardner IA; Greiner M; Dubey JP
Zoonoses Public Health; 2010 Feb; 57(1):82-94. PubMed ID: 19744298
[TBL] [Abstract][Full Text] [Related]
20. Weak associations between prognostic biomarkers and disease in preliminary studies illustrates the breach between statistical significance and diagnostic discrimination.
Levinson SS
Clin Chim Acta; 2010 Apr; 411(7-8):467-73. PubMed ID: 20083096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
